+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5701962
Description Jump to:
The report titled Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market - Growth, Future Prospects, and Competitive Analysis, 2022 - 2030; offers strategic insights into the overall ABSSSI treatment market along with the market size and estimates for the duration 2020 to 2030. The said research study cover in-depth analysis of multiple market segments based on type of infection, pathogen, drug, and different geographies. According to market experts acute skin and skin structure infections (ABSSSI) comprise set of bacterial infections that involve multiple layers of the skin and associated tissues. These infections tend to be more severe in nature than simple infections of the skin, and they usually require systemic antibacterial therapy and patient hospitalization. The majority of ABSSSIs are caused by Gram-positive bacterial strains, especially Staphylococcus aureus. However, Gram-negative bacteria has high importance in specific types of infections, as well as in hospital settings.

For the purpose of this study, the global ABSSSI treatment market is segmented on the basis of drugs type into Delafloxacin, Vancomycin, Ceftaroline fosamil, Telvancin, Oritavancin, Tedizolid, Daptomycin, Tigecycline, Linezolid, TMP-SMZ, and Others.

The global ABSSSI treatment market is also segmented on the basis of type of infections into cellulitis, abscess/boil/cyst, surgical wound, and traumatic wound.

The global ABSSSI treatment market is segmented on the basis of type of pathogens such as Methicillin sensitive Staphylococcus aureus (MSSA), Methicillin resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, and Others.

The geographical segmentation of ABSSSI treatment market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries.

The ABSSSI treatment market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Furiex Pharmaceuticals, Inc., GlaxoSmithKline plc, Melinta Therapeutics, Inc, Debiopharm International S.A., MerLion Pharmaceuticals Pte Ltd., Durata Therapeutics, Inc., Paratek Pharmaceuticals, Inc. and Cempra, Inc. among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drug

  • Delafloxacin
  • Vancomycin
  • Ceftaroline fosamil
  • Telvancin
  • Oritavancin
  • Tedizolid
  • Daptomycin
  • Tigecycline
  • Linezolid
  • TMP-SMZ
  • Others (Doxycycline, Levofloxacin, Metronidazole, and Others)

Infection

  • Cellulitis
  • Abscess/Boil/Cyst
  • Surgical Wound
  • Traumatic Wound

Pathogen

  • Methicillin sensitive Staphylococcus aureus (MSSA)
  • Methicillin resistant Staphylococcus aureus (MRSA)
  • Beta-hemolytic Streptococcus
  • Escherichia coli
  • Enterococcus faecalis
  • Pseudomonas aeruginosa
  • Others

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market?
  • Which is the largest regional market for Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
2.2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Drug, 2021 (US$ Million)
2.3. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Infection, 2021 (US$ Million)
2.4. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Pathogen, 2021 (US$ Million)
2.5. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Geography, 2021 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2021
3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Vendors
3.2. Strategies Adopted by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Delafloxacin
5.3.2. Vancomycin
5.3.3. Ceftaroline fosamil
5.3.4. Telvancin
5.3.5. Oritavancin
5.3.6. Tedizolid
5.3.7. Daptomycin
5.3.8. Tigecycline
5.3.9. Linezolid
5.3.10. TMP-SMZ
5.3.11. Others (Doxycycline, Levofloxacin, Metronidazole, and Others)
6. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Cellulitis
6.3.2. Abscess/Boil/Cyst
6.3.3. Surgical Wound
6.3.4. Traumatic Wound
7. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2021 Versus 2030
7.3. Market Segmentation
7.3.1. Methicillin sensitive Staphylococcus aureus (MSSA)
7.3.2. Methicillin resistant Staphylococcus aureus (MRSA)
7.3.3. Beta-hemolytic Streptococcus
7.3.4. Escherichia coli
7.3.5. Enterococcus faecalis
7.3.6. Pseudomonas aeruginosa
7.3.7. Others
8. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
8.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
8.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
8.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2020-2030, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
8.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
8.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
8.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
8.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
8.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
8.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
9. UK and European Union Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
9.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
9.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
9.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2020-2030, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
9.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
9.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
9.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
9.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
9.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
9.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
9.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
9.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
9.5.1.5. France
9.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
9.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
9.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
9.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
9.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
10. Asia Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
10.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
10.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
10.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2020-2030, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
10.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
10.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
10.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
10.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
10.5.1.3. India
10.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
10.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
10.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
10.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
10.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
10.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
10.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
10.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
10.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
11. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
11.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
11.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
11.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2020-2030, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
11.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
11.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
11.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
11.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
11.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
11.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
12. Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2020-2030, USD (Million)
12.1. Market Overview
12.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
12.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
12.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
12.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2020-2030, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
12.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
12.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
12.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
12.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2020-2030, USD (Million)
12.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2020-2030, USD (Million)
12.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2020-2030, USD (Million)
13. Company Profile
13.1. Furiex Pharmaceuticals, Inc.
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. GlaxoSmithKline plc
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Melinta Therapeutics, Inc.
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Debiopharm International S.A.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. MerLion Pharmaceuticals Pte Ltd.
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Durata Therapeutics, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Paratek Pharmaceuticals, Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Cempra, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Abbott Laboratories, Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Actelion Pharmaceuticals Ltd.
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Albany Molecular Research, Inc.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Allergan plc.
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. AstraZeneca
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Bayer AG
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Macrolide Pharmaceuticals, Inc.
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Merck & Co, Inc.
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
13.17. Pfizer, Inc.
13.17.1. Company Overview
13.17.2. Financial Performance
13.17.3. Product Portfolio
13.17.4. Strategic Initiatives
13.18. Sanofi
13.18.1. Company Overview
13.18.2. Financial Performance
13.18.3. Product Portfolio
13.18.4. Strategic Initiatives
13.19. Teva Pharmaceuticals Industries Ltd.
13.19.1. Company Overview
13.19.2. Financial Performance
13.19.3. Product Portfolio
13.19.4. Strategic Initiatives
13.20. Zavante Therapeutics, Inc.
13.20.1. Company Overview
13.20.2. Financial Performance
13.20.3. Product Portfolio
13.20.4. Strategic Initiatives
List of Figures
Figure 1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Quality Assurance
Figure 5 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Drug, 2021
Figure 6 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Infection, 2021
Figure 7 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Pathogen, 2021
Figure 8 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Geography, 2021
Figure 9 Market Geographical Opportunity Matrix - Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2021
Figure 10 Market Positioning of Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Players, 2021
Figure 11 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 12 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Drug, 2021 Vs 2030, %
Figure 13 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Infection, 2021 Vs 2030, %
Figure 14 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Pathogen, 2021 Vs 2030, %
Figure 15 U.S. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 16 Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 17 Rest of North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 18 UK Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 19 Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 20 Spain Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 21 Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 22 France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 23 Rest of Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 24 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 25 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 26 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 27 Australia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 28 South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 29 Rest of Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 30 Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 31 Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 32 Rest of Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 33 GCC Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 34 Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
Figure 35 Rest of Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 4 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 5 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 6 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 7 U.S. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 8 U.S. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 9 U.S. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 10 Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 11 Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 12 Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 13 Rest of North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 14 Rest of North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 15 Rest of North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 16 UK and European Union Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 17 UK and European Union Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 18 UK and European Union Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 19 UK Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 20 UK Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 21 UK Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 22 Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 23 Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 24 Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 25 Spain Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 26 Spain Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 27 Spain Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 28 Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 29 Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 30 Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 31 France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 32 France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 33 France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 34 Rest of Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 35 Rest of Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 36 Rest of Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 37 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 38 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 39 Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 40 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 41 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 42 China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 43 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 44 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 45 Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 46 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 47 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 48 India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 49 Australia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 50 Australia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 51 Australia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 52 South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 53 South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 54 South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 55 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 56 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 57 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 58 Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 59 Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 60 Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 61 Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 62 Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 63 Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 64 Rest of Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 65 Rest of Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 66 Rest of Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 67 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 68 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 69 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 70 GCC Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 71 GCC Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 72 GCC Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 73 Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 74 Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 75 Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)
Table 76 Rest of Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Drug, 2020-2030, USD (Million)
Table 77 Rest of Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection, 2020-2030, USD (Million)
Table 78 Rest of Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Pathogen, 2020-2030, USD (Million)

Companies Mentioned

  • Furiex Pharmaceuticals Inc.
  • GlaxoSmithKline plc
  • Melinta Therapeutics Inc
  • Debiopharm International S.A.
  • MerLion Pharmaceuticals Pte Ltd.
  • Durata Therapeutics Inc.
  • Paratek Pharmaceuticals Inc.
  • Cempra Inc.

Related Topics

Related Reports

Acute Bacterial Skin and Skin Structure Infections Market by Type of Infection, Route of Administration, Distribution Channel, and By Region - Product Image

Acute Bacterial Skin and Skin Structure Infections Market by Type of Infection, Route of Administration, Distribution Channel, and By Region

  • Report
  • 200 Pages
  • Global
From
Acute Bacterial Skin and Skin Structure Infections Global Market Report 2024 - Product Image

Acute Bacterial Skin and Skin Structure Infections Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Acute Bacterial Skin and Skin Structure Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Acute Bacterial Skin and Skin Structure Infections Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 140 Pages
  • Global
From
Acute Bacterial Skin and Skin Structure Infections - Pipeline Insight, 2024 - Product Image

Acute Bacterial Skin and Skin Structure Infections - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Acute Bacterial Skin & Skin Structure Infection Market by Infection Type, Disease Category, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Acute Bacterial Skin & Skin Structure Infection Market by Infection Type, Disease Category, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.